The Norwegian Cerebral Venous Thrombosis Study

NCT05021198 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2025-02-05

No results posted yet for this study

Summary

The NoCVT study will investigate CVT (2014-2023) in a large Norwegian population (\> 3 millions) using several approaches combining existing health registries, clinical databases and new prospectively collected clinical data to explore epidemiology, risk factors, diagnostics, treatment, and the long-term prognosis of CVT.

Conditions

  • Cerebral Vein Thrombosis
  • Cerebral Venous Sinus Thrombosis

Sponsors & Collaborators

  • Oslo University Hospital

    collaborator OTHER
  • Haukeland University Hospital

    collaborator OTHER
  • Drammen sykehus

    collaborator OTHER
  • Sorlandet Hospital HF

    collaborator OTHER_GOV
  • St. Olavs Hospital

    collaborator OTHER
  • Nordlandssykehuset HF

    collaborator OTHER
  • University Hospital of North Norway

    collaborator OTHER
  • University of Oslo

    collaborator OTHER
  • Rigshospitalet, Denmark

    collaborator OTHER
  • Hospital de Santa Maria, Portugal

    collaborator OTHER
  • Sykehuset Innlandet HF

    collaborator OTHER
  • Molde Hospital

    collaborator OTHER
  • Helse Stavanger HF

    collaborator OTHER_GOV
  • Sykehuset Telemark

    collaborator OTHER_GOV
  • Sykehuset i Vestfold HF

    collaborator OTHER
  • University Hospital, Akershus

    lead OTHER

Principal Investigators

  • Espen Saxhaug Kristoffersen, MD, PhD · University Hospital, Akershus

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-01
Primary Completion
2026-12-31
Completion
2027-01-31

Countries

  • Norway

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05021198 on ClinicalTrials.gov